• The New Money
  • Posts
  • Bringing AI To Eyewear, Brin's Psychedelic Bet, And New Funding For Lithium Refinement

Bringing AI To Eyewear, Brin's Psychedelic Bet, And New Funding For Lithium Refinement

Uncovering the world’s most exciting early stage companies. Discover what’s next.

Bringing Artificial Intelligence To Eyewear

KITS Eyecare (TSX: KITS) has announced the launch of a new line of eyewear known as Pangolin Smart Glasses, which allow individuals to seamlessly use artificial intelligence technology through vision and sound - giving them the ability to send messages, connect directly to the Internet, and even ask questions to OpenAI’s ChatGPT.

Google's Co-Founder Is Backing A Psychedelic Startup

Sergey Brin, a co-founder of Google, has backed psychedelic medicine startup Soneira with a new $15 million investment to advance their novel molecules that are derived from ibogaine. Although ibogaine treatments have been validated in clinical research to have promise for treating addiction, Soneira is exploring ibogaine compounds as a potential breakthrough treatment for Traumatic Brain Injury.

A New Government Grant For Lithium Refinement

Telescope Innovations (CSE:TELI) has been awarded grant funding from the British Columbia Centre for Innovation and Clean Energy to advance their proprietary method for producing battery grade lithium carbonate from saltwater brine in a carbon negative process.

The Sprint

  • Nvidia (NASDAQ:NVDA) purchased $3.7M million of equity in Serve Robotics (NASDAQ: SERV), bringing their ownership stake to over 10%.

  • Engage Labs has launched a new technology platform which enables individuals to donate crypto to political campaigns in the United States, built upon Coinbase’s layer 2 blockchain.

New here? Join our community of 25,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.